MENTOR GEL-FILLED BREAST IMPLANT SALES MAY CONTINUE
This article was originally published in The Gray Sheet
Executive Summary
MENTOR GEL-FILLED BREAST IMPLANT SALES MAY CONTINUE beyond the date for market removal specified in the company's product liability settlement agreement, the company said March 29. Under the settlement agreement, which was approved by the federal court in September ("The Gray Sheet" Sept. 13, 1993. p. 1), the company was required to cease manufacturing and selling silicone-gel breast implants "within 18 months from October 1993."
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.